arrow
A

Ashwin N. Ananthakrishnan

massachusetts general hospital
H指数:99
被引数:4.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Upadacitinib Is Associated with the Lowest Risk of Treatment Failure Among Advanced Therapies for Ulcerative Colitis: A Real-World Administrative Claims Study

乌帕替尼在溃疡性结肠炎高级疗法中与最低的治疗失败风险相关:一项真实世界行政索赔研究

2026-09-290
PRE
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age

奥扎尼妥(Ozanimod)在按年龄分层的中度至重度活动性溃疡性结肠炎患者中的安全性与有效性

2025-11-010
PRE
Patient-Level Dynamics of Clinical Response to Mirikizumab and Its Impact on Quality of Life: Analysis From the Vivid-1 Trial in Crohn's Disease

克罗恩病患者对Mirikizumab临床反应的个体水平动态及其对生活质量的影响:来自Vivid-1试验的分析

2025-10-010
PRE
Long-Term Ozanimod Therapy in Patients With Moderately Active Ulcerative Colitis After Failure of 5-Aminosalicylic Acid

奥扎尼莫德长期治疗对5-氨基水杨酸治疗失败的轻中度溃疡性结肠炎患者的疗效

2025-09-010
OAAI